Downey Max C, Gacki-Smith Jessica, Kuramitsu Brianna, Vanterpool Karen B, Nordstrom Michelle, Luken Michelle, Langlee Whitney, Riggleman Tiffany, Fichter Shannon, Altema Withney, Jensen Sally E, Dumanian Gregory A, Cooney Carisa M, Levan Macey L, Tintle Scott, Brandacher Gerald, Gordon Elisa J
Department of Surgery, NYU Grossman School of Medicine, New York, NY, USA.
Center for Health Services and Outcomes Research, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
SAGE Open Med. 2023 Jul 13;11:20503121231184677. doi: 10.1177/20503121231184677. eCollection 2023.
Upper extremity vascularized composite allotransplantation is an innovative treatment option for people with upper extremity amputations. Limited patient-relevant long-term outcomes data about transplant success may impede patients' informed treatment decision-making. We assessed perceptions of what constitutes upper extremity vascularized composite allotransplantation success among individuals with upper extremity amputations.
This multisite study entailed interviews and focus groups with individuals with upper extremity amputations and upper extremity vascularized composite allotransplantation candidates, participants, and recipients. We examined perceptions of transplant success and preferences for five upper extremity vascularized composite allotransplantation outcomes. Qualitative data were analyzed using thematic analysis; and quantitative data were analyzed using descriptive statistics.
In all, 50 individuals participated in interviews (61.7% participation rate), and 37 participated in nine focus groups (75.5% participation rate). Most were White (72%, 73%), had a mean age of 45 and 48 years, and had a unilateral amputation (84%, 59%), respectively. Participants conceptualized upper extremity vascularized composite allotransplantation success as transplant outcomes: (1) restoring function and sensation to enable new activities; (2) accepting the transplanted limb into one's identity and appearance; (3) not having transplant rejection; (4) attaining greater quality of life compared to prosthetics; and (5) ensuring benefits outweigh risks. Participants rated their most important upper extremity vascularized composite allotransplantation outcomes as follows: not having transplant rejection, not developing health complications, grasping objects, feeling touch and temperature, and accepting the upper extremity vascularized composite allotransplantation into your identity.
Individuals with upper extremity amputations maintain several conceptions of vascularized composite allotransplantation success, spanning functional, psychosocial, clinical, and quality of life outcomes. Providers should address patients' conceptions of success to improve informed consent discussions and outcomes reporting for upper extremity vascularized composite allotransplantation.
上肢血管化复合组织异体移植是上肢截肢患者的一种创新治疗选择。关于移植成功的与患者相关的长期结果数据有限,可能会阻碍患者做出明智的治疗决策。我们评估了上肢截肢患者对上肢血管化复合组织异体移植成功的构成要素的看法。
这项多中心研究包括对上肢截肢患者以及上肢血管化复合组织异体移植候选者、参与者和接受者进行访谈和焦点小组讨论。我们研究了对移植成功的看法以及对五种上肢血管化复合组织异体移植结果的偏好。定性数据采用主题分析法进行分析;定量数据采用描述性统计进行分析。
共有50人参与了访谈(参与率为61.7%),37人参与了9个焦点小组讨论(参与率为75.5%)。大多数人是白人(分别为72%、73%),平均年龄分别为45岁和48岁,并且均为单侧截肢(分别为84%、59%)。参与者将上肢血管化复合组织异体移植成功概念化为移植结果:(1)恢复功能和感觉以实现新的活动;(2)在身份认同和外观上接受移植肢体;(3)不发生移植排斥;(4)与假肢相比获得更高的生活质量;(5)确保益处大于风险。参与者对他们最重要的上肢血管化复合组织异体移植结果的评分如下:不发生移植排斥、不出现健康并发症、抓握物体、感知触觉和温度、在身份认同上接受上肢血管化复合组织异体移植。
上肢截肢患者对血管化复合组织异体移植成功有多种概念,涵盖功能、心理社会、临床和生活质量结果。医疗服务提供者应关注患者对成功的概念,以改善上肢血管化复合组织异体移植的知情同意讨论和结果报告。